These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22980697)

  • 1. Health technology reassessment of non-drug technologies: current practices.
    Leggett L; Noseworthy TW; Zarrabi M; Lorenzetti D; Sutherland LR; Clement FM
    Int J Technol Assess Health Care; 2012 Jul; 28(3):220-7. PubMed ID: 22980697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of health technology reassessment of non-drug technologies: survey and key informant interviews.
    Leggett LE; Mackean G; Noseworthy TW; Sutherland L; Clement F
    Health Res Policy Syst; 2012 Dec; 10():38. PubMed ID: 23241276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DRUG DISINVESTMENT FRAMEWORKS: COMPONENTS, CHALLENGES, AND SOLUTIONS.
    Maloney MA; Schwartz L; O'Reilly D; Levine M
    Int J Technol Assess Health Care; 2017 Jan; 33(2):261-269. PubMed ID: 28703087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review on current status of health technology reassessment: insights for South Korea.
    Seo HJ; Park JJ; Lee SH
    Health Res Policy Syst; 2016 Nov; 14(1):82. PubMed ID: 27835964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge translation and health technology reassessment: identifying synergy.
    Esmail R; Hanson H; Holroyd-Leduc J; Niven DJ; Clement F
    BMC Health Serv Res; 2018 Aug; 18(1):674. PubMed ID: 30165846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health technology reassessment: the art of the possible.
    MacKean G; Noseworthy T; Elshaug AG; Leggett L; Littlejohns P; Berezanski J; Clement F
    Int J Technol Assess Health Care; 2013 Oct; 29(4):418-23. PubMed ID: 24290335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disinvestment in healthcare: an overview of HTA agencies and organizations activities at European level.
    Calabrò GE; La Torre G; de Waure C; Villari P; Federici A; Ricciardi W; Specchia ML
    BMC Health Serv Res; 2018 Mar; 18(1):148. PubMed ID: 29490647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioethics, health technology reassessment, and management.
    Soril LJ; Clement FM; Noseworthy TW
    Healthc Manage Forum; 2016 Nov; 29(6):275-278. PubMed ID: 27744278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moving low value care lists into action: prioritizing candidate health technologies for reassessment using administrative data.
    Soril LJJ; Seixas BV; Mitton C; Bryan S; Clement FM
    BMC Health Serv Res; 2018 Aug; 18(1):640. PubMed ID: 30111308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UNTANGLING, UNBUNDLING, AND MOVING FORWARD: FRAMING HEALTH TECHNOLOGY REASSESSMENT IN THE CHANGING CONCEPTUAL LANDSCAPE.
    Soril LJJ; Niven DJ; Esmail R; Noseworthy TW; Clement FM
    Int J Technol Assess Health Care; 2018 Jan; 34(2):212-217. PubMed ID: 29616604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STATUS OF DISINVESTMENT INITIATIVES IN LATIN AMERICA: RESULTS FROM A SYSTEMATIC LITERATURE REVIEW AND A QUESTIONNAIRE.
    Agirrezabal I; Burgon J; Stewart G; Gutierrez-Ibarluzea I
    Int J Technol Assess Health Care; 2017 Jan; 33(6):674-680. PubMed ID: 28956521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HEALTH TECHNOLOGY DISINVESTMENT WORLDWIDE: OVERVIEW OF PROGRAMS AND POSSIBLE DETERMINANTS.
    Orso M; de Waure C; Abraha I; Nicastro C; Cozzolino F; Eusebi P; Montedori A
    Int J Technol Assess Health Care; 2017 Jan; 33(2):239-250. PubMed ID: 28669355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustainability of healthcare systems in Asia: exploring the roles of horizon scanning and reassessment in the health technology assessment landscape.
    Mundy L; Trowman R; Kearney B
    Int J Technol Assess Health Care; 2020 Jun; 36(3):262-269. PubMed ID: 32389130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of knowledge translation theories, models and frameworks for health technology reassessment: expert perspectives through a qualitative exploration.
    Esmail R; Clement FM; Holroyd-Leduc J; Niven DJ; Hanson HM
    BMC Health Serv Res; 2021 Apr; 21(1):401. PubMed ID: 33926430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a How-to-Guide for Health Technology Reassessment: "The HTR Playbook".
    Soril LJJ; Elshaug AG; Esmail R; Chalkidou K; Gad M; Clement FM
    Int J Health Policy Manag; 2022 Dec; 11(11):2525-2532. PubMed ID: 35065545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DISINVESTING FROM INEFFECTIVE TECHNOLOGIES: LESSONS LEARNED FROM CURRENT PROGRAMS.
    Mayer J; Nachtnebel A
    Int J Technol Assess Health Care; 2015; 31(6):355-62. PubMed ID: 26694654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deliberative process of health technology reassessment by health technology assessment agency in Korea.
    Shin S; Kim Y; Choi J; Park JY;
    Int J Technol Assess Health Care; 2024 May; 40(1):e28. PubMed ID: 38738417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to choose health technologies to be assessed by HTA? A review of criteria for priority setting.
    Specchia ML; Favale M; Di Nardo F; Rotundo G; Favaretti C; Ricciardi W; de Waure C;
    Epidemiol Prev; 2015; 39(4 Suppl 1):39-44. PubMed ID: 26499414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health technology reassessment in the Brazilian public health system: Analysis of the current status.
    Pereira VC; Barreto JOM; Neves FADR
    PLoS One; 2019; 14(7):e0220131. PubMed ID: 31356609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scanning the horizon of obsolete technologies: possible sources for their identification.
    Ibargoyen-Roteta N; Gutierrez-Ibarluzea I; Asua J; Benguria-Arrate G; Galnares-Cordero L
    Int J Technol Assess Health Care; 2009 Jul; 25(3):249-54. PubMed ID: 19619342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.